What challenges remain in chronic myeloid leukemia research?

In the last fifteen years, the advent of imatinib has opened a new era in the treatment of CML. The challenge now is to eradicate the disease. To do this, groundbreaking scientific and biological studies should lead to the development of new techniques that can eliminate the last leukemic cells.